Cibc Private Wealth Group, LLC Sarepta Therapeutics, Inc. Transaction History

Cibc Private Wealth Group, LLC

$56.1 Billion
Q3 2025

A detailed history of Cibc Private Wealth Group, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 275 shares of SRPT stock, worth $5,172. This represents 0.0% of its overall portfolio holdings.

Number of Shares

275

Previous 518 46.91%

Holding current value

$5,172

Previous $33,000 84.85%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 21, 2025	SELL	$11.93 - $21.97 $2,898 - $5,338	-243 Reduced 46.91%	275 $5,000
Q1 2025 May 14, 2025	BUY	$63.82 - $127.89 $319 - $639	5 Added 0.97%	518 $33,000
Q4 2024 Feb 12, 2025	SELL	$104.54 - $137.94 $19,548 - $25,794	-187 Reduced 26.71%	513 $62,000
Q3 2024 Nov 13, 2024	BUY	$124.33 - $156.75 $29,341 - $36,993	236 Added 50.86%	700 $87,000
Q2 2024 Aug 09, 2024	SELL	$113.33 - $163.85 $906 - $1,310	-8 Reduced 1.69%	464 $73,000

Q1 2024 May 10, 2024	BUY	$93.7 - $141.53 $44,226 - $66,802	472 New	472 $61,000
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $644,973 - $1.02 Million	8,519 Added 141983.33%	8,525 $942,000
Q2 2022 Aug 03, 2022	BUY	$62.69 - $88.44 $376 - $530	6 New	6 $0
Q2 2021 Aug 16, 2021	SELL	$69.38 - $86.75 $189,546 - $237,001	-2,732 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$72.25 - $168.95 $105,196 - $245,991	-1,456 Reduced 34.77%	2,732 $204,000
Q4 2020 Feb 12, 2021	SELL	$125.56 - $178.74 $169,757 - $241,656	-1,352 Reduced 24.4%	4,188 $714,000
Q3 2020 Nov 03, 2020	BUY	$127.12 - $172.34 $704,244 - $954,763	5,540 New	5,540 $778,000
Q2 2020 Aug 13, 2020	SELL	$93.0 - $171.7 $609,057 - $1.12 Million	-6,549 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $77,354 - $123,609	-939 Reduced 12.54%	6,549 $641,000
Q4 2019 Jan 30, 2020	SELL	$76.53 - $135.58 $9,413 - $16,676	-123 Reduced 1.62%	7,488 $966,000
Q3 2019 Oct 16, 2019	SELL	$72.81 - $156.91 $41,283 - $88,967	-567 Reduced 6.93%	7,611 $573,000
Q2 2019 Jul 31, 2019	SELL	$112.21 - $151.95 $103,120 - $139,642	-919 Reduced 10.1%	8,178 $1.24 Million
Q1 2019 May 10, 2019	BUY	$106.67 - $151.68 $41,281 - $58,700	387 Added 4.44%	9,097 $1.08 Million
Q4 2018 Feb 05, 2019	SELL	$97.32 - $148.76 $56,932 - $87,024	-585 Reduced 6.29%	8,710 $950,000
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $16,719 - $23,418	145 Added 1.58%	9,295 $1.5 Million
Q2 2018 Aug 02, 2018	SELL	$71.74 - $153.69 $9,326 - $19,979	-130 Reduced 1.4%	9,150 $1.21 Million
Q1 2018 May 17, 2018	SELL	$54.02 - $82.27 $32,412 - $49,362	-600 Reduced 6.07%	9,280 $688,000
Q4 2017 Feb 12, 2018	BUY	$47.64 - $56.75 $9,051 - $10,782	190 Added 1.96%	9,880 $550,000
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $346,223 - $456,883	9,690	9,690 $440,000

Others Institutions Holding SRPT

# of Institutions

406

Shares Held

83.7M

Call Options Held

5.27M

Put Options Held

5.94M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $1.65B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc Private Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cibc Private Wealth Group, LLC with notifications on news.

Account

Cibc Private Wealth Group, LLC Sarepta Therapeutics, Inc. Transaction History